cvt 124 has been researched along with rolofylline in 2 studies
| Studies (cvt 124) | Trials (cvt 124) | Recent Studies (post-2010) (cvt 124) | Studies (rolofylline) | Trials (rolofylline) | Recent Studies (post-2010) (rolofylline) |
|---|---|---|---|---|---|
| 18 | 2 | 0 | 112 | 29 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gottlieb, SS | 1 |
| Dohadwala, MM; Givertz, MM | 1 |
2 review(s) available for cvt 124 and rolofylline
| Article | Year |
|---|---|
Adenosine A1 antagonists and the cardiorenal syndrome.
Topics: Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Diseases; Kidney Function Tests; Male; Mice; Prognosis; Randomized Controlled Trials as Topic; Receptor, Adenosine A1; Risk Assessment; Severity of Illness Index; Syndrome; Treatment Outcome; Xanthines | 2008 |
Role of adenosine antagonism in the cardiorenal syndrome.
Topics: Adenosine A1 Receptor Antagonists; Animals; Heart Failure; Hospital Mortality; Humans; Kidney Failure, Chronic; Registries; Syndrome; Xanthines | 2008 |